NewsNovo
The case for Biomerica's (Nasdaq: BMRA) $2.23 million private placement, which closed August 26, 2026, centers on the institutional anchor: B.
Riley Principal Capital, LLC joined the company's own directors and executive officers at $1.60 per share for 1,393,705 new shares.
Riley's participation came attached to a governance right, and the registration clock that started on closing day now gives the Irvine, California company 30 days to file a resale statement or begin paying.
The deal was placed under the Section 4(a)(2) exemption and Rule 506 of Regulation D, keeping it outside the public registration process for now. Under the Securities Purchase Agreement dated August 20, B.
Keep reading